Abiomed receives HDE Supplement Approval for AbioCor Artificial HeartAbiomed atarax.

Abiomed receives HDE Supplement Approval for AbioCor Artificial HeartAbiomed, Inc. announced that it has U.S atarax . Food and Drug Administration Humanitarian Device Exemption supplement approval on system upgrades for its implantable Replacement Heart received AbioCo . The AbioCor is the severely damaged native heart for patients who are ineligible for transplantation to replace and have no other treatment option. The AbioCor is replaced by the body’s blood circulation and is designed to. Lives of patients who would otherwise die of heart failure, which also extend to a probable benefit for a satisfactory quality of life The AbioCor is the first completely self-contained artificial heart, which allow patients more time at home, without wires or tubes piercing through their skin. This technology provides patients with complete mobility and remote diagnostics. This is a momentous day for Abiomed and advanced heart failure patients, roll out receive again their natural heart or a transplant We have leading U.S. Hospitals, the chosen , the AbioCor program and expect patient implants with AbioCor start in spring 2008, said Michael R. Minogue, Chairman, CEO and President of Abiomed. Robert Wood Johnson University Hospital in New Brunswick, NJ, Texas Heart Institute at St. Luke’s Episcopal Hospital in Houston, and St Johns Hopkins Hospital in Baltimore, MD: – Abiomed four sites four sites as AbioCor Centers including date. Vincent Hospital in Indianapolis.

The talent abdominal stent Graft is the stent graft of choice for physicians internationally in recent years. Around 1.2 million of the device received CE Mark and has been commercially used in Europe since 2002. The earliest version of the Talent Abdominal Stent Graft was first used clinically in Australia in 1995.

The new phase II multicenter trial, Irvale are by intravenous a 30 minute infusion every 3 weeks for administered. The primary endpoint will be progression-free survival. Do The Phase I studies Irvale, showed an excellent safety.